US Brand Head - Obesity Liver

Boehringer Ingelheim; Ridgefield (CT); Presencial; USD 262 000 - 394 000; Tempo integral

Vantagens oferecidas por esta oferta de emprego

Discretionary bonus

Relocation assistance

Total rewards programs

Resumo da oferta

Boehringer Ingelheim in Ridgefield, CT seeks a seasoned leader to head the US Obesity Liver brand, guiding launch readiness and lifecycle management. You will shape strategy across regulatory, commercial, and medical functions to maximize market impact.

The role requires deep US marketplace acumen, strong cross-functional leadership, and a track record of successful launches in the US with global collaboration. This on-site role offers hybrid flexibility.

Qualificações

• Minimum of 12 years of experience in the pharmaceutical/healthcare industry across multiple disciplines (marketing, sales, product development, market access, etc.).
• Previous launch experience in US and collaboration with global teams highly preferred.
• Strong strategic, analytical and leadership capabilities to drive a US obesity liver brand from PoC to mature lifecycle.

Responsabilidades

• Lead and drive the US Brand Head for Obesity Liver across its lifecycle, including PoC to launch and mature brand phases.
• Develop and execute a forward-looking, integrated brand strategy maximizing commercial value while ensuring regulatory/compliance integrity.
• Collaborate with cross-functional launch readiness efforts and global teams to deliver a US-ready brand plan.
• Own brand P&L, revenue forecasting, budgets and cost-effective execution for successful market introduction and ongoing growth.
• Provide strategic direction to US Brand Team members across Marketing, Medical Affairs, Market Access and Program Leads.

Conhecimentos

Strategic thinking

Analytical skills

Cross-functional collaboration

Leadership

Formação académica

Bachelor’s degree in business/science or related field

MBA or science-related graduate degree preferred

Descrição da oferta de emprego

The base salary range for this position is $262,400 to $393,600. The position may be eligible for a role-specific discretionary bonus, relocation assistance, and/or other compensation elements. We continuously review market data and may adjust salary ranges as needed in the future. Actual compensation will be based on job-related factors such as skills, experience, qualifications, and other factors permitted by law. Benefits include medical, dental, and vision coverage, retirement savings opportunities, paid time off, paid holidays, disability and life insurance benefits, and other company-sponsored benefits. For additional information regarding our benefits and Total Rewards offerings.

Compensation Data

The base salary range for this position is $262,400 to $393,600. The position may be eligible for a role-specific discretionary bonus, relocation assistance, and/or other compensation elements. We continuously review market data and may adjust salary ranges as needed in the future. Actual compensation will be based on job-related factors such as skills, experience, qualifications, and other factors permitted by law. Benefits include medical, dental, and vision coverage, retirement savings opportunities, paid time off, paid holidays, disability and life insurance benefits, and other company-sponsored benefits. For additional information regarding our benefits and Total Rewards offerings.

Description

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides an opportunity for all employees to collaborate internationally, offering visibility and the opportunity to directly contribute to the company’s success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim’s high regard for our employees.

The US Brand Head - Obesity Liver is responsible for leading and driving the success of a product launch and commercial brand strategy for a brand across its entire lifecycle, from Proof of Concept (PoC) through launch and into the mature brand phase. This role ensures the development and execution of a forward-looking, integrated brand strategy that maximizes commercial value of the brand while ensuring and integrity at every stage. As the brand progresses through its life cycle, the focus of the Brand Head evolves to address the specific needs, challenges, and opportunities of each development phase. They possess broad multi-functional expertise, including deep US marketplace acumen, solid understanding of both the US regulatory and drug development environment, and the US legal and compliance landscape.

This role is accountable for driving the brand to a successful launch ensuring the achievement of strategic and launch objectives while maintaining a life-cycle perspective. The role emphasizes market preparation, launch readiness, and brand development activities, with a strong focus on collaboration with cross-functional launch readiness efforts, particularly co-creating with the Global market to deliver a US-ready brand plan. This includes steering the ambition (financial forecasts), establishing appropriate cross-functional shared metrics, ensuring that resources (budgets and staff) required for a successful launch are secured within the appropriate functional budgets.

The US Brand Head - Obesity Liver delivers and refines the US Brand Plan for alignment with therapeutic area priorities and launch objectives. This includes overseeing market development activities and ensuring effective implementation through collaboration with and as a standing member of the Global Launch Brand Team.

This role integrates cross-functional strategies into a comprehensive launch plan and leads a motivated, outcome-driven team while fostering a performance-driven culture based on trust and psychological safety. As the US point of accountability, the Brand Head is given full responsibility for brand success with decision-making authority for strategic decisions, risk mitigation, budget ownership and cost-effective execution to accelerate brand launches and maximize market impact – all in a compliant manner across all activities. The Executive Director, US Non-Priority Brand Head is fully accountable to ensure compliance across all functions and guarantees that diverse perspectives are represented in strategic decision-making.

This role is based on-site at our Ridgefield, CT location with hybrid flexibility of 2-3 days per week on-site.

Duties & Responsibilities

• Member of the global cross-functional team of leaders that co-create and execute a comprehensive, ambitious, compliant and deliverable Brand launch strategy in alignment with brand priorities and the overall TA portfolio/disease area
• Key contact for global leadership collaboration across all functions in the US
• Provides strategic leadership for US Brand Team members (Marketing, Medical Affairs, Market Access and Program Leads) to ensure cross-functional alignment and seamless execution across the Value & Evidence Networks balancing & considering the input from all functional leads (Medicine, Marketing, Value and Access)
• Owns overall success of launch and beyond in the US
• Responsible for all launch metrics, timelines, workstream collaboration, risk management, and mitigation strategies tied to joint launch KPI's
• Accountable for the supervision, development, and growth of US Brand Team members
• Strives to build a highly motivated, cohesive, and outcome-driven US Brand Team, promoting a culture of trust, performance, innovation, integrity and psychological safety, enabling the acceleration of transformative therapies
• Drives commercial, financial and other key strategic decisions and endorses & integrates line function strategies into a consolidated US Brand strategy in a balanced manner
• Accountable for driving alignment across cross-functional teams to ensure that their strategies inform tactics and deliverables
• Manage internal interfaces to ensure cohesive execution
• Ensure all strategies are clearly referenced with documented insights and external proof, demonstrating a robust external focus and alignment with market needs.
• Owns the US brand P&L, including revenue forecasting, investment prioritization, budget management, and delivery of financial and operational objectives
• Accountable for delivering US product forecasts, ensuring consistency and accuracy in financial and market projections including IAP and long-term forecast discussions
• Develop annual objectives and budgets as well as deployment of department resources to meet financial and operational objectives and to ensure they have the budget and resources to support pre-launch activities
• Accountable for integrating, following up on, and mitigating risks based on insights from the launch readiness process, ensuring seamless execution and market success

Requirements

• Bachelor's degree in business, science or related field required; MBA or science- related graduate degree preferred
• Proven strategic and analytical skills with a minimum of twelve (12) years of experience in the pharmaceutical and healthcare industry in multiple disciplines such as marketing, sales, consulting, product development, business development, market access, government affairs or related experience
• Previous experience in the Obesity market strongly preferred
• Previous launch experience including a minimum of one year of recent launch experience in the US and experience working with global are highly preferred
• Strong understanding of market dynamics and knowledge on how to execute on bringing a product from development to market in the US
• Knowledge of both the US environment, the global organization and an understanding of how it works
• Demonstrates strong strategic skills, business acumen, and a proven ability to drive impactful decisions
• Experienced in commercialization, including a working understanding of patient and market access as well as specialty distribution models